Opportunity
Federal Register #CDC2026-0563
CDC Requests Public Comment on TB Follow-Up Data Collection for Newly Arrived Persons and Status Adjusters
Buyer
Centers for Disease Control and Prevention
Posted
April 14, 2026
Respond By
June 15, 2026
Identifier
CDC2026-0563
NAICS
923120
The Centers for Disease Control and Prevention (CDC), under the Department of Health and Human Services, is seeking public comment on a proposed data collection initiative to support tuberculosis (TB) follow-up for newly arrived individuals and U.S. status adjusters with TB classifications. - Government Buyer: - Centers for Disease Control and Prevention (CDC) - Department of Health and Human Services - Project Overview: - Proposed information collection titled "U.S. Tuberculosis Follow-Up Worksheet for Newly Arrived Persons and U.S. Status Adjusters with Tuberculosis Classifications" - Utilizes the Electronic Disease Notification (EDN) System - Data collected from state and local health departments - Data Collected: - Chest x-rays - TB diagnoses - Treatment outcomes - Purpose: - Improve tracking and monitoring of individuals with overseas TB classifications - Support national TB prevention programs - Notable Requirements: - Accurate and comprehensive data collection for domestic follow-up evaluations - No procurement of products or services; this is a request for information and public comment - OEMs and Vendors: - No OEMs or vendors are specified, as this is not a procurement action
Description
The Centers for Disease Control and Prevention (CDC) is seeking public comment on a proposed information collection project titled "U.S. Tuberculosis Follow-Up Worksheet for Newly Arrived Persons and U.S. Status Adjusters with Tuberculosis Classifications." This worksheet is designed to capture tuberculosis examination information for newly arrived persons and U.S. status adjusters with TB classifications to improve national TB prevention programs. The data collection will assist in monitoring and tracking persons with overseas TB classifications and evaluating domestic follow-up outcomes to prevent new TB transmission in the U.S.